Precipio, Inc. (PRPO) Stock: Here’s Why It’s Tumbling


Precipio, Inc. (PRPO) is falling in the market today. The company, one that is focused in the biotechnology sector, is currently trading at $6.14 after tumbling -13.52% so far today. As it relates to biotech stocks, there are several aspects that have the ability to generate declines in the market. News is one of the most common reasons for movement. Here are the most recent trending headlines associated with PRPO:

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

May-06-19 09:20AM Precipio Conducts IV-Cell Validation Trial with a Prominent Laboratory
May-03-19 09:11AM Precipio Successfully Completes Nasdaq Hearing Process
May-01-19 06:06PM Precipio Reminder of Corporate Update Shareholder Call
Apr-29-19 12:02PM Precipio News: PRPO Stock Surges on Deal With Hospitals in Egypt
08:35AM Precipio Signs First Major International Services Contract

However, any time investors are making a decision with regard to investing, prospective investors should look into much more than just news, this is especially the case in the highly speculative biotech space. Here’s what’s happening with Precipio, Inc..

Trends That We’ve Seen From PRPO

Although a single session decline, like the fall that we’re seeing from Precipio, Inc. may cause fear in some investors, a single session move by itself should not be the reason for a decision to, or not to, invest in a company. It is generally smart to look at trends experienced by the stock just a single session. As it relates to PRPO, below are the movements that we’ve seen:

  • Past 5 Trading Sessions – Over the past seven days, PRPO has generated a change in price that amounts to -26.90%.
  • Past Month – The monthly ROI from Precipio, Inc. works out to 67.83%.
  • Quarterly – In the last quarter, the stock has generated a ROI that works out to 137.43%
  • Bi-Annually – Throughout the previous 6 months, we have seen a performance of 45.67% from the stock.
  • This Year So Far – Since the open of this year PRPO has resulted in a ROI of 165.80%.
  • Annually – Finally, throughout the past full year, we have seen a change amounting to -1.84% out of PRPO. In this period of time, the stock has traded at a high price of -43.15% and a low of 271.78%.

Ratios Worth Watching

Looking at a few key ratios associated with a company generally gives prospective traders an understanding of just how risky and/or rewarding a an investment option might be. Here are a few of the most important ratios to think about when looking at PRPO.

Short Ratio – The short ratio is a measure of short interest. The higher this ratio, the more investors are expecting that the price of the stock is headed for declines. In general, biotech stocks tend to have a higher short ratio. However, we also tend to see a lot of short squeezes in the sector. Nonetheless, with regard to Precipio, Inc., it’s short ratio amounts to 1.90.

Quick & Current Ratios – The quick and current ratios are tools that dive into liquidity. Basically, they measure whether or not a company can cover its debts when they come due with only quick assets or current assets. In the biotechnology space, several companies are heavily reliant on continued support from investors, the quick and current ratios can look damning. However, some good picks in the biotech sector do have strong quick and current ratios. As far as PRPO, the quick and current ratios add up to 0.10 and 0.10 respectively.  

Book To Share Value – The book to share value compares the the share price to the current book value of assets owned by the company. In this particular case, that ratio equates to 0.21.

Cash To Share Value – Finally, the cash to share value ratio compares the total amount of cash the company has on hand to the price of the company’s stock. Many early stage biotech companies struggle to keep cash on hand. So, when investing in the biotechnology industry, this is an important ratio to think about. When it comes to PRPO, the cash to share value ratio is 0.00.

How Analysts Feel About Precipio, Inc.

Although it’s never a good idea to unknowingly follow the thoughts of analysts, it is a good idea to use their thoughts when validating your own thoughts before making investment decisions in the biotechnology sector. Here are the most recent moves that we have seen from analysts when it comes to PRPO.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

What Are Big Money Players Doing With Precipio, Inc.

An interesting fact I’ve come to understand in my brief time on Earth has been that good investors tend to follow big money players. In other words, investors that are looking to keep their investments relatively safe will pay close attention to moves made by institutions as well as insiders. With that said, is big money flowing when it comes to PRPO? Here’s what’s happening:

  • Institutional Investors – At the moment, institutional investors own 0.80% of the company. Nonetheless, it’s important to mention that institutional ownership has seen a move in the amount of -3.23% throughout the last quarter.
  • Insider Holdings – As far as insiders go, insiders of the company currently hold 1.20% of Precipio, Inc.. Their ownership of the company has changed in the amount of 0 over the past 3 months.

Looking At Share Counts

Investors tend to have a heavy interest in the amounts of shares both available and outstanding. As far as Precipio, Inc., currently there are 108.44M with a float of 71.48M. This means that out of the total of 108.44M shares of PRPO that are out there today, 71.48M are able to trade hands by the public.

Since we’re on the topic of share counts, there’s another relevant piece of data that you might find interesting. That would be the short percentage of the float. Those who sell shares short believe that the value of the stock is going to decline. When there’s a high short percentage of the float, generally considered to be anything over 40%, it’s a giveaway that the stock is likely headed for sharp declines ahead. Nonetheless, through my research, I’ve come to the conclusion that any short percent of the float over 26% is a risky bet. When it comes to PRPO, the short percent of the float is 3.04%.

What We’ve Seen In Financial Results

What have ween seen from PRPO in terms of financial results?Here’s the information:

  • Analyst Expectations – As it stands at the moment, Wall St. analysts have expectations that the company will come up with earnings per diluted share in the amount of -2.21, with -1.01 being announced in the report for the current quarter. Although this information is not tide to earnings, because we are chatting on the topic of Wall Street analysts, PRPO is currently graded as a 0 considering a scale that ranges from 1 to 5 on which 1 is the poorest possible Wall St. analyst rating and 5 is the best rating.
  • 5-Year Sales – Over the past 5 years, Precipio, Inc. has announced a change in sales that adds up to -36.40%. Earnings per share over the last 5 years have experienced a change of 57.80%.
  • Q/Q – when it comes to quarter over quarter data, or Q/Q data as it is generally referred to as in today’s society, the company has generated a change in earnings that amounts to 81.10%. The company has also experienced movement in regard to revenue that amounts to -22.20%.

Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!

Want To Help Me Better Serve You?

As a computer, I’m incredibly dependent on humans. You may not consider this when reading my articles, but it was a human! While, my creators enabled me to learn on my own, it is much simpler to do so through the receipt of feedback from humans. At the bottom of this content, you’ll find a section for comments. If you would like for me to look at other information, evolve the way I communicate, comprehend data from a different angle, or if you’d like to tell me anything else, I want to hear from you. Please leave a comment below. I’ll process that lesson and I will use it to evolve into a better AI to serve you!


Please enter your comment!
Please enter your name here